The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal Carcinoma

Shuzhan Li,Wei Dai,Ngar-Woon Kam,Jiali Zhang,Victor H. F. Lee,Xiubao Ren,Dora Lai-Wan Kwong

DOI: https://doi.org/10.3390/cancers16071312

2024-03-29

Cancers

Abstract:Endemic nasopharyngeal carcinoma (NPC) is closely associated with the Epstein–Barr virus (EBV), which contributes to tumor development and influences the tumor immune microenvironment (TIME) in NPC. Natural killer (NK) cells, as part of the innate immune system, play a crucial role in responding to viral infections and malignant cell transformations. Notably, NK cells possess a unique ability to target tumor cells independent of major histocompatibility complex class I (MHC I) expression. This means that MHC I-deficient tumor cells, which can escape from effective T cell attack, are susceptible to NK-cell-mediated killing. The activation of NK cells is determined by the signals generated through inhibitory and activating receptors expressed on their surface. Understanding the role of NK cells in the complex TIME of EBV+ NPC is of utmost importance. In this review, we provide a comprehensive summary of the current understanding of NK cells in NPC, focusing on their subpopulations, interactions, and cytotoxicity within the TIME. Moreover, we discuss the potential translational therapeutic applications of NK cells in NPC. This review aims to enhance our knowledge of the role of NK cells in NPC and provide valuable insights for future investigations.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the role of natural killer cells (NK cells) in the tumor - immune microenvironment of EBV - related nasopharyngeal carcinoma (EBV+NPC) and their complex interactions with the tumor - immune microenvironment (TIME). Specifically, the paper explores the following aspects:

1. **The role of NK cells in EBV+NPC**:
- The paper describes in detail the multiple functions of NK cells in EBV+NPC, including their antiviral and antitumor capabilities.
- It particularly emphasizes the unique ability of NK cells to recognize and kill tumor cells lacking major histocompatibility complex class I (MHC I) expression, which can evade the attack of other parts of the immune system (such as CD8+T cells).

2. **The interaction between NK cells and the tumor - immune microenvironment**:
- The paper discusses how NK cells interact with other cells and molecules in the tumor microenvironment through different signaling pathways (such as activation and inhibition receptors).
- It describes the distribution of NK cells in the tumor microenvironment and the performance of different subsets of NK cells in tumor tissues, especially the changes in recurrent or metastatic EBV+NPC.

3. **The functional state and regulatory mechanisms of NK cells**:
- The paper summarizes various factors that affect the function of NK cells, including the interaction between cell - surface receptors and their ligands, the influence of cytokines and chemokines, and the regulation of NK cell function by immune checkpoint molecules.
- It specifically mentions the expression of some key immune checkpoint molecules (such as PD - 1, TIGIT, LAG3, etc.) on NK cells and their impact on NK cell function.

4. **Potential treatment strategies**:
- The paper also discusses the possibility of using the antitumor potential of NK cells for treatment, including enhancing the activity of NK cells or overcoming their inhibitory state in the tumor microenvironment to improve the treatment effect.

In summary, this paper aims to comprehensively summarize and understand the role of NK cells in EBV+NPC and their interaction with the tumor - immune microenvironment, and provide new perspectives and directions for future research and treatment.